IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus

Clinical trial NCT01234974 · WITHDRAWN

Trial details

NCT number: NCT01234974
Sponsor: Milton S. Hershey Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2010-12-01
Primary completion: 2012-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.